NEXAF
2026
The Norwegian Exercise in Atrial Fibrillation Trial
In 295 inactive adults with non-permanent atrial fibrillation, a 12-month supervised-then-home exercise programme reduced AF burden and AF-specific quality of life at 12 months compared with usual care.
Résultat
- Différence absolue
- 3,2 points
- NNT
- 32
relative reduction45P = 0,016
La différence absolue et le NNT sont dérivés des taux d’événements.
Également rapporté: But the co-primary quality-of-life score did not differ (AFEQT +5.6 vs +4.4; P = 0.43). Fitness rose and resting heart rate fell; total hospitalisations were 37% lower and AF-related hospitalisations 46% lower.
- Sous-thème
- Exercise
- Schéma
- multicentre (Trondheim, Bærum/Drammen, Tromsø), open-label, two-arm RCT; 1:1 supervised plus eHealth-based exercise vs usual care; blinded statistical analysis; 12-month follow-up with insertable cardiac monitor
- Pertinence
- Important: l’un des piliers parmi d’autres.
- Source
- Nes BM, et al. Presented at ESC Congress 2026, Hot Line 8, 30 August.
Discussion et critique
Exercise halves the time spent in atrial fibrillation, measured by an implanted monitor rather than by symptoms, the cleanest evidence yet that the arrhythmia itself responds to training. The second co-primary endpoint did not move: patients did not feel better, the same dissociation between rhythm and symptoms that the sham-controlled ablation trial in this session found. Open-label against usual care, 295 patients, and the hospitalisation figures are secondary and unadjusted for multiplicity.